Hinge Health, Inc. (HNGE) - Stock Analysis
Last updated: May 9, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Healthcare momentum candidate with strong execution: Q1 revenue was $182M, up 47% YoY and ahead of expectations, margins improved, management raised full-year revenue guidance, and Q1 free cash flow was $41.6M. Stock is up about 25% over the last 21 trading days with only a modest pullback from its recent high.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Cash Generation ⢠Margin Strength ⢠SBC Drag HNGE showed a sharp quarterly turnaround with strong gross margins, positive cash flow, and manageable debt, but annual losses, heavy stock-based compensation, and a still-rich valuation remain key risks.
Price Behavior
Key Price Behavior Insights: ⢠Higher highs ⢠Breakout hold ⢠Stretched momentum Support Level: $49.75-$48.89 Resistance Level: $45-$46 HNGE's last month trend is strongly bullish, with a breakout above $45-$46 and support now at $49.75-$48.89, though the sharp run from the mid-$40s to $56.02 leaves it stretched and vulnerable to a pause.
Sentiment & News
Key News Insights: ⢠Revenue surge ⢠Guidance raise ⢠Migraine launch Hinge Health posted record Q1 2026 results with 47% revenue growth, margin expansion, and raised full-year guidance, while also expanding into migraine care and drawing stronger investor attention.
AI Summary
HNGE now looks less like a speculative digital health growth story and more like a scalable cash-generating business, with Q1 showing strong revenue growth, 84.5% gross margin, and real free cash flowâbut the stock likely needs continued >40% growth and disciplined control of stock-based compensation/dilution to justify the rerating.
Description
Hinge Health develops software for musculoskeletal care, providing digital programs and services that support treatment of acute injuries, chronic pain and post-operative rehabilitation. The company also offers administrative and operational support to health plans and employers. Founded in 2012, it is headquartered in San Francisco, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| May 14 | May 21 | HNGE | Hinge Health, Inc. | Healthcare momentum candidate with strong execution: Q1 revenue was $182M, up 47% YoY and ahead of expectations, margins improved, management raised full-year revenue guidance, and Q1 free cash flow was $41.6M. Stock is up about 25% over the last 21 trading days with only a modest pullback from its recent high. | Active | +0.0% |